Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...

Randi Skaug will lead an all-women expedition through Norway’s most remarkable landscapes, all the while teaching tangible ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Mostly clear. Patchy fog. Lows in the mid 40s. South winds around 5 mph. Mostly clear in the evening then becoming partly cloudy. Not as cool with lows in the upper 50s. South winds around 5 mph.